BIOMAT Database Logo BIOMAT Database Logo

Poor tolerance of zidovudine in an HIV-asymptomatic patient with alpha-thalassemia. 1991

D Vittecoq, and E Delabesse, and M Bary, and R Girot, and N Maier Redelsperger, and J F Bach

UI MeSH Term Description Entries
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D004909 Erythrocyte Indices ERYTHROCYTE size and HEMOGLOBIN content or concentration, usually derived from ERYTHROCYTE COUNT; BLOOD hemoglobin concentration; and HEMATOCRIT. The indices include the mean corpuscular volume (MCV), the mean corpuscular hemoglobin (MCH), and the mean corpuscular hemoglobin concentration (MCHC). Erythrocyte Hemoglobin, Mean Cell,Erythrocyte Size Determination,Erythrocyte Volume, Mean Cell,Hemoglobin, Erythrocyte, Mean Cell,Mean Corpuscular Volume,Red Cell Indices,Erythrocyte Diameter,Erythrocyte Index,Erythrocyte Indexes,Erythrocyte Thickness,Mean Cell Hemoglobin Concentration,Mean Cell Volume,Mean Corpuscular Hemoglobin,Mean Corpuscular Hemoglobulin Concentration,Red Cell Distribution Width,Red Cell Index,Red Cell Indexes,Cell Volumes, Mean,Corpuscular Volumes, Mean,Determination, Erythrocyte Size,Determinations, Erythrocyte Size,Diameter, Erythrocyte,Diameters, Erythrocyte,Erythrocyte Diameters,Erythrocyte Size Determinations,Hemoglobin, Mean Corpuscular,Hemoglobins, Mean Corpuscular,Index, Erythrocyte,Index, Red Cell,Indexes, Erythrocyte,Indexes, Red Cell,Indices, Erythrocyte,Indices, Red Cell,Mean Cell Volumes,Mean Corpuscular Hemoglobins,Mean Corpuscular Volumes,Size Determination, Erythrocyte,Size Determinations, Erythrocyte,Thickness, Erythrocyte,Volume, Mean Cell,Volume, Mean Corpuscular,Volumes, Mean Cell,Volumes, Mean Corpuscular
D005260 Female Females
D006454 Hemoglobins The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements. Eryhem,Ferrous Hemoglobin,Hemoglobin,Hemoglobin, Ferrous
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

D Vittecoq, and E Delabesse, and M Bary, and R Girot, and N Maier Redelsperger, and J F Bach
Zidovudine overdose in an asymptomatic HIV seropositive patient with hemophilia.
January 1992, Psychosomatics,
D Vittecoq, and E Delabesse, and M Bary, and R Girot, and N Maier Redelsperger, and J F Bach
[Rapid development of anemia in a HIV-positive patient with alpha-thalassemia after zidovudine therapy].
July 2007, Mikrobiyoloji bulteni,
D Vittecoq, and E Delabesse, and M Bary, and R Girot, and N Maier Redelsperger, and J F Bach
[Tolerance of zidovudine in patients with beta-thalassemia].
April 1989, Presse medicale (Paris, France : 1983),
D Vittecoq, and E Delabesse, and M Bary, and R Girot, and N Maier Redelsperger, and J F Bach
Zidovudine in asymptomatic HIV infection.
September 1990, The New England journal of medicine,
D Vittecoq, and E Delabesse, and M Bary, and R Girot, and N Maier Redelsperger, and J F Bach
Zidovudine in asymptomatic HIV infection.
December 1993, The New England journal of medicine,
D Vittecoq, and E Delabesse, and M Bary, and R Girot, and N Maier Redelsperger, and J F Bach
Zidovudine in asymptomatic HIV infection.
December 1993, The New England journal of medicine,
D Vittecoq, and E Delabesse, and M Bary, and R Girot, and N Maier Redelsperger, and J F Bach
Zidovudine in asymptomatic HIV infection.
December 1993, The New England journal of medicine,
D Vittecoq, and E Delabesse, and M Bary, and R Girot, and N Maier Redelsperger, and J F Bach
[Zidovudine in asymptomatic HIV infection].
August 1991, Medizinische Monatsschrift fur Pharmazeuten,
D Vittecoq, and E Delabesse, and M Bary, and R Girot, and N Maier Redelsperger, and J F Bach
[Zidovudine for asymptomatic HIV patients?].
October 1994, Deutsche medizinische Wochenschrift (1946),
D Vittecoq, and E Delabesse, and M Bary, and R Girot, and N Maier Redelsperger, and J F Bach
[Zidovudine plus didanosine in HIV infected asymptomatic patients previously treated with zidovudine].
January 1998, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
Copied contents to your clipboard!